Live from the NIH registry
Studies recruiting near Poughkeepsie right now
Top 25 of 78 recruiting studies, sorted by proximity — each links to its official registry page
Tracking Results of Ablations to Combat AF Registry Generation 2
Atrial Fibrillation
N/A
Observational 10,000 participants sought
Vassar Brothers Medical Center — Poughkeepsie, New York (0.4 mi)
· Sponsor: AtriCure, Inc.
Depemokimab as an Extended treatmeNt Duration Biologic in Adults With Chronic Obstructive Pulmonary Disease (COPD) and Type 2 Inflammation (ENDURA-2)
Pulmonary Disease, Chronic Obstructive
Phase 3
Interventional 960 participants sought
GSK Investigational Site — New Windsor, New York (16.0 mi)
· Sponsor: GlaxoSmithKline
Novel Bioactive Sleeve on Pain and PROMs
Meniscus Tear
N/A
Interventional 100 participants sought
Orlin and Cohen Orthopedics — Woodbury, New York (24.8 mi)
· Sponsor: Northwell Health
Zilebesiran in Patients With Hypertension Not Adequately Controlled and With Either Established Cardiovascular Disease or High Risk for Cardiovascular Disease
High Risk Cardiovascular Disease, Hypertension
Phase 3
Interventional 11,000 participants sought
Clinical Trial Site — Poughkeepsie, New York (0.4 mi)
· Sponsor: Alnylam Pharmaceuticals
Examining the Most Effective Method to Reduce Running Ground Contact Time
Healthy Runners
N/A
Interventional 30 participants sought
Keller Army Community Hospital — West Point, New York (21.0 mi)
· Sponsor: Keller Army Community Hospital
Anticoagulation in ICH Survivors for Stroke Prevention and Recovery
Intracerebral Hemorrhage, Atrial Fibrillation
Phase 3
Interventional 700 participants sought
Vassar Brothers Medical Center — Poughkeepsie, New York (0.4 mi)
· Sponsor: Yale University
Effect of Dalcetrapib on CV Risk in a Genetically Defined Population With a Recent ACS
Acute Coronary Syndrome
Phase 3
Interventional 2,000 participants sought
Research Site — Poughkeepsie, New York (0.4 mi)
· Sponsor: DalCor Pharmaceuticals
A Study Investigating Subcutaneously Administered Pozelimab in Combination With Cemdisiran or Cemdisiran Alone in Adult Participants With Geographic Atrophy
Age-related Macular Degeneration (AMD), Geographic Atrophy (GA)
Phase 3
Interventional 975 participants sought
Seeta Eye center — Poughkeepsie, New York (0.4 mi)
· Sponsor: Regeneron Pharmaceuticals
Study to Assess the Impact of the Urine Test Cxbladder Triage Plus on the Number of Cystoscopies Performed on Patients With Invisible Blood in Their Urine.
Hematuria - Cause Not Known
N/A
Interventional 1,000 participants sought
Premier Medical Group of the Hudson Valley, P. C. — Poughkeepsie, New York (0.4 mi)
· Sponsor: Pacific Edge Limited
Testing Higher Dose Radiation Therapy for Locally Advanced Pancreatic Cancer
Locally Advanced Unresectable Pancreatic Ductal Adenocarcinoma, Stage II Pancreatic Cancer AJCC v8
Phase 3
Interventional 356 participants sought
Vassar Brothers Medical Center — Poughkeepsie, New York (0.4 mi)
· Sponsor: NRG Oncology
Collection of Samples USOPTIVAL Study
Colorectal Cancer (CRC), Advanced Adenomas (AA)
N/A
Observational 1,300 participants sought
Mid Hudson Medical Research — New Windsor, New York (16.0 mi)
· Sponsor: Universal Diagnostics
Efficacy, Safety, and Tolerability Study of Lunsekimig Compared With Placebo in Adult Participants With Inadequately Controlled Chronic Obstructive Pulmonary Disease (COPD), Characterized by an Eosinophilic Phenotype
Chronic Obstructive Pulmonary Disease
Phase 3
Interventional 942 participants sought
Mid Hudson Medical Research - New Windsor- Site Number : 8400004 — New Windsor, New York (16.0 mi)
· Sponsor: Sanofi
A Study for Subjects With Prostate Cancer Who Previously Participated in an Enzalutamide Clinical Study
Prostate Cancer
Phase 2
Interventional 900 participants sought
Hudson Valley Urology, PC — Poughkeepsie, New York (0.4 mi)
· Sponsor: Astellas Pharma Global Development, Inc.
A Study Assessing Corneal Endothelial Cells in Participants With Neovascular Age-related Macular Degeneration (nAMD) Treated With the Port Delivery System With Ranibizumab (PDS)
Neovascular Age-related Macular Degeneration
Phase 4
Interventional 188 participants sought
Seeta Eye Centers — Poughkeepsie, New York (0.4 mi)
· Sponsor: Genentech, Inc.
A Study to Learn About the Study Medicine Called PF-07799544 as Monotherapy or in Combination in People With Advanced Solid Tumors
Melanoma, Glioma
Phase 1
Interventional 124 participants sought
Optum Medical Care, PC — Brewster, New York (25.9 mi)
· Sponsor: Pfizer
Prospective Study to Assess a Diagnostic Aid for Cancer
Cancer
N/A
Observational 1,650 participants sought
Westchester Putnam Gastro — Carmel, New York (22.1 mi)
· Sponsor: Harbinger Health
A Study to Evaluate KarXT as a Treatment for Psychosis Associated With Alzheimer's Disease (ADEPT-4)
Alzheimer Disease
Phase 3
Interventional 406 participants sought
Mid Hudson Medical Research PLLC — New Windsor, New York (16.0 mi)
· Sponsor: Karuna Therapeutics, Inc., a Bristol Myers Squibb company
A Study to Evaluate the Efficacy and Safety of IMG-007 in Adult Participants With Moderate-to-Severe Atopic Dermatitis
Atopic Dermatitis, Atopic Dermatitis Eczema
Phase 2
Interventional 405 participants sought
Inmagene Site 11 — Woodbury, New York (24.8 mi)
· Sponsor: Inmagene LLC
A Study Evaluating the Efficacy and Safety of Pegozafermin in Participants With MASH and Fibrosis (ENLIGHTEN-Fibrosis)
Metabolic Dysfunction-Associated Steatotic Liver Disease (MASH) / Nonalcoholic Steatohepatitis (NASH) With Fibrosis
Phase 3
Interventional 1,350 participants sought
89bio Clinical Study Site — Carmel, New York (22.1 mi)
· Sponsor: 89bio, Inc.
A Clinical Study of MK-2214 in People With Early Alzheimer's Disease (MK-2214-004)
Early Alzheimer's Disease
Phase 2
Interventional 340 participants sought
Mid Hudson Medical Research ( Site 1050) — New Windsor, New York (16.0 mi)
· Sponsor: Merck Sharp & Dohme LLC
A Study of Once-daily Oral ASC30 to Evaluate the Efficacy and Safety in Adult Participants With Obesity or Overweight With Type 2 Diabetes
Obesity, Overweight
Phase 3
Interventional 1,560 participants sought
AURORA-2 Clinical Site — New Windsor, New York (16.0 mi)
· Sponsor: Ascletis Pharma (China) Co., Limited
Trial of Therapeutic Cancer Vaccine OSE2101 in Patients With Non-Small Cell Lung Cancer and Secondary Resistance to Immune Checkpoint Inhibitor
Patients With Non-Small Cell Lung Cancer
Phase 3
Interventional 363 participants sought
Optum Medical Care - Poughkeepsie — Poughkeepsie, New York (0.4 mi)
· Sponsor: OSE Immunotherapeutics
A Study to Compare Two Surgical Procedures in Individuals With BRCA1 Mutations to Assess Reduced Risk of Ovarian Cancer
Ovarian Carcinoma
N/A
Interventional 1,956 participants sought
Vassar Brothers Medical Center — Poughkeepsie, New York (0.4 mi)
· Sponsor: NRG Oncology
Diuretics Alone vs. Aortix Endovascular Device for Acute Heart Failure
Heart Failure, Cardiorenal Syndrome
N/A
Interventional 320 participants sought
Nuvance Health — Poughkeepsie, New York (0.4 mi)
· Sponsor: Procyrion
Maridebart Cafraglutide in Heart Failure With Preserved or Mildly Reduced Ejection Fraction and Obesity
Heart Failure With Preserved Ejection Fraction, Heart Failure With Mildly Reduced Ejection Fraction
Phase 3
Interventional 5,056 participants sought
Hudson Valley Cardiovascular Practice PC — Poughkeepsie, New York (0.4 mi)
· Sponsor: Amgen